Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer
Details
Publication Year 2023-04,Volume 25,Issue #4,Page 1124-1131
Journal Title
Clinical & Translational Oncology
Publication Type
Research article
Abstract
PURPOSE: Triple-negative breast cancer (TNBC) is characterized by large heterogeneity and relative lack of available targeted therapies. To find therapeutic strategies for distinct patients with TNBC, several approaches have been used for TNBC clustering, including recently immune and phosphoproteomic patterns. Based on 70-kDa ribosomal protein S6 kinase (P70S6K)-TNBC clustering, the current study explores the immune profiling in TNBC tumors. METHODS: Stromal tumor-infiltrating lymphocytes (sTILs) were evaluated in human TNBC tumor samples. Furthermore, immunohistochemistry staining for CD8, CD4, Foxp3, and CD20 was performed in tissue microarrays (TMA) sections. RESULTS: Histological analysis showed decreased sTILs, CD20(+) cells, and CD8(+)/CD4(+) ratio in high phosphorylated P70S6K (p-P70S6K) tumors. Moreover, p-P70S6K score was directly correlated with CD4(+) and Foxp3(+) T cells, while it was inversely correlated with CD8(+)/CD4(+) and CD8(+)/Foxp3(+) ratios. CONCLUSION: sTIL infiltration and lymphocyte profiling vary in the context of hyperactivation of P70S6K in TNBC tumors.
Publisher
Springer Nature
Keywords
Humans; *Lymphocytes, Tumor-Infiltrating/metabolism; *Triple Negative Breast Neoplasms/pathology; Prognosis; Ribosomal Protein S6 Kinases, 70-kDa/metabolism/therapeutic use; Forkhead Transcription Factors/metabolism/therapeutic use; Biomarkers, Tumor/metabolism; B cells; P70s6k; T cells; Til; Tnbc
Department(s)
Laboratory Research
PubMed ID
36508123
Open Access at Publisher's Site
https://doi.org/10.1007/s12094-022-03006-3
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-07-25 05:27:40
Last Modified: 2023-07-25 05:28:06

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙